Rosenblatt Maintains Buy on Imax, Raises Price Target to $65
Benzinga Newsdesk 1 month ago
NewsPrice TargetAnalyst Ratings
Rosenblatt analyst Steve Frankel maintains Imax (NYSE:IMAX) with a Buy and raises the price target from $60 to $65.
Rosenblatt analyst Steve Frankel maintains Imax (NYSE:IMAX) with a Buy and raises the price target from $60 to $65.